These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35316690)

  • 1. Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study.
    Cochran G; Charron E; Brown JL; Cernasev A; Hohmeier KC; Winhusen TJ
    Drug Alcohol Depend; 2022 May; 234():109406. PubMed ID: 35316690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between elevated depressive symptoms and substance use, prescription opioid misuse, overdose history, pain, and general health among community pharmacy patients prescribed opioids.
    Brown JL; Cochran G; Bryan MA; Charron E; Winhusen TJ
    Subst Abus; 2022; 43(1):1110-1115. PubMed ID: 35499399
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid medication misuse among unhealthy drinkers.
    Cochran G; McCarthy R; Gordon AJ; Tarter RE
    Drug Alcohol Depend; 2017 Oct; 179():13-17. PubMed ID: 28735077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pain Severity and Interference and Substance Use Among Community Pharmacy Patients Prescribed Opioids: A Secondary Analysis of the PHARMSCREEN Study.
    Charron E; Okifuji A; Bryan MA; Reese S; Brown JL; Ferguson A; Ghitza UE; Winhusen T; Cochran G
    J Pain; 2022 Aug; 23(8):1448-1459. PubMed ID: 35417791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic variation in the provision of naloxone by pharmacies in Ontario, Canada: A population-based small area variation analysis.
    Antoniou T; McCormack D; Campbell T; Sutradhar R; Tadrous M; Lum-Wilson N; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2020 Nov; 216():108238. PubMed ID: 32891910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study.
    Gomes T; Juurlink DN; Antoniou T; Mamdani MM; Paterson JM; van den Brink W
    PLoS Med; 2017 Oct; 14(10):e1002396. PubMed ID: 28972983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescription opioid use: Patient characteristics and misuse in community pharmacy.
    Cochran G; Bacci JL; Ylioja T; Hruschak V; Miller S; Seybert AL; Tarter R
    J Am Pharm Assoc (2003); 2016; 56(3):248-256.e6. PubMed ID: 27053277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis.
    Cochran G; Hruschak V; Bacci JL; Hohmeier KC; Tarter R
    Res Social Adm Pharm; 2017 Nov; 13(6):1055-1061. PubMed ID: 27876595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: A population-based study.
    Antoniou T; Men S; Tadrous M; Leece P; Munro C; Gomes T
    Drug Alcohol Depend; 2022 Jul; 236():109473. PubMed ID: 35523113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.
    Kim TW; Walley AY; Heeren TC; Patts GJ; Ventura AS; Lerner GB; Mauricio N; Saitz R
    J Subst Abuse Treat; 2017 Oct; 81():1-10. PubMed ID: 28847449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient, prescriber, and Community factors associated with filled naloxone prescriptions among patients receiving buprenorphine 2017-18.
    Stein BD; Jones CM; Smart R; Sheng F; Sorbero M
    Drug Alcohol Depend; 2021 Apr; 221():108569. PubMed ID: 33578296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse.
    Cochran G; Rubinstein J; Bacci JL; Ylioja T; Tarter R
    J Addict Med; 2015; 9(5):411-6. PubMed ID: 26291546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees.
    Cochran G; Lo-Ciganic WH; Gellad WF; Gordon AJ; Cole E; Lobo C; Frazier W; Zheng P; Chang CH; Kelley D; Donohue JM
    J Manag Care Spec Pharm; 2018 Sep; 24(9):875-885. PubMed ID: 30156454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with naloxone availability and dispensing through Michigan's pharmacy standing order.
    Dahlem CH; Myers M; Goldstick J; Stevenson JG; Gray G; Rockhill S; Dora-Laskey A; Kellenberg J; Brummett CM; Kocher KE
    Am J Drug Alcohol Abuse; 2022 Jul; 48(4):454-463. PubMed ID: 35405078
    [No Abstract]   [Full Text] [Related]  

  • 15. Overdose risk for veterans receiving opioids from multiple sources.
    Jasuja GK; Ameli O; Miller DR; Land T; Bernson D; Rose AJ; Berlowitz DR; Smelson DA
    Am J Manag Care; 2018 Nov; 24(11):536-540. PubMed ID: 30452210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. If we build it, will they come? Perspectives on pharmacy-based naloxone among family and friends of people who use opioids: a mixed methods study.
    Slocum S; Ozga JE; Joyce R; Walley AY; Pollini RA
    BMC Public Health; 2022 Apr; 22(1):735. PubMed ID: 35418048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of concurrent use of stimulants and opioids among people who access harm reduction services in British Columbia, Canada: Findings from the 2019 Harm Reduction Client Survey.
    Lukac CD; Steinberg A; Papamihali K; Mehta A; Lock K; Buxton JA
    Int J Drug Policy; 2022 Apr; 102():103602. PubMed ID: 35124412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining risk of prescription opioid overdose: pharmacy shopping and overlapping prescriptions among long-term opioid users in medicaid.
    Yang Z; Wilsey B; Bohm M; Weyrich M; Roy K; Ritley D; Jones C; Melnikow J
    J Pain; 2015 May; 16(5):445-53. PubMed ID: 25681095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beliefs Associated with Pharmacy-Based Naloxone: a Qualitative Study of Pharmacy-Based Naloxone Purchasers and People at Risk for Opioid Overdose.
    Donovan E; Case P; Bratberg JP; Baird J; Burstein D; Walley AY; Green TC
    J Urban Health; 2019 Jun; 96(3):367-378. PubMed ID: 30747371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high-strength opioids for chronic non-cancer pain: An explorative intervention development study.
    Mercer F; Parkes T; Foster R; Steven D; McAuley A; Baldacchino A; Steele W; Schofield J; Matheson C
    Drug Alcohol Rev; 2023 Mar; 42(3):517-526. PubMed ID: 36165733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.